Tuis22UA • FRA
add
BioNTech SE - ADR
Vorige sluiting
€90,95
Dagwisseling
€90,20 - €92,85
Jaarwisseling
€69,70 - €124,60
Markkapitalisasie
24,05 mjd USD
Gemiddelde volume
811,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(EUR) | Des. 2024info | J/J-verandering |
---|---|---|
Inkomste | 1,19 mjd | -19,54% |
Bedryfskoste | 816,80 m | 15,68% |
Netto inkomste | 259,50 m | -43,33% |
Netto winsgrens | 21,81 | -29,55% |
Wins per aandeel | 1,08 | -43,16% |
EBITDA | 295,10 m | -52,96% |
Effektiewe belastingkoers | 13,84% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(EUR) | Des. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 16,78 mjd | 1,42% |
Totale bates | 22,53 mjd | -2,07% |
Totale aanspreeklikheid | 3,12 mjd | 12,98% |
Totale ekwiteit | 19,41 mjd | — |
Uitstaande aandele | 240,28 m | — |
Prys om te bespreek | 1,13 | — |
Opbrengs op bates | 1,44% | — |
Opbrengs op kapitaal | 1,66% | — |
Kontantvloei
Netto kontantverandering
(EUR) | Des. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 259,50 m | -43,33% |
Kontant van bedrywe | -463,30 m | -154,45% |
Kontant van beleggings | 606,70 m | 122,51% |
Kontant van finansiering | -7,30 m | 43,41% |
Netto kontantverandering | 137,30 m | 107,49% |
Beskikbare kontantvloei | -174,31 m | -130,65% |
Meer oor
BioNTech SE is a global biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
HUB
Gestig
2008
Webwerf
Werknemers
6 772